Determination of Glass Transition Temperature of Polyimides from Atomistic Molecular Dynamics Simulations and Machine-Learning Algorithms
Authors:
Chengyuan Wen,
Binghan Liu,
Josh Wolfgang,
Timothy E. Long,
Roy Odle,
Shengfeng Cheng
Abstract:
Glass transition temperature ($T_{\text{g}}$) plays an important role in controlling the mechanical and thermal properties of a polymer. Polyimides are an important category of polymers with wide applications because of their superior heat resistance and mechanical strength. The capability of predicting $T_{\text{g}}$ for a polyimide $a~priori$ is therefore highly desirable in order to expedite th…
▽ More
Glass transition temperature ($T_{\text{g}}$) plays an important role in controlling the mechanical and thermal properties of a polymer. Polyimides are an important category of polymers with wide applications because of their superior heat resistance and mechanical strength. The capability of predicting $T_{\text{g}}$ for a polyimide $a~priori$ is therefore highly desirable in order to expedite the design and discovery of new polyimide polymers with targeted properties and applications. Here we explore three different approaches to either compute $T_{\text{g}}$ for a polyimide via all-atom molecular dynamics (MD) simulations or predict $T_{\text{g}}$ via a mathematical model generated by using machine-learning algorithms to analyze existing data collected from literature. Our simulations reveal that $T_{\text{g}}$ can be determined from examining the diffusion coefficient of simple gas molecules in a polyimide as a function of temperature and the results are comparable to those derived from data on polymer density versus temperature and actually closer to the available experimental data. Furthermore, the predictive model of $T_{\text{g}}$ derived with machine-learning algorithms can be used to estimate $T_{\text{g}}$ successfully within an uncertainty of about 20 degrees, even for polyimides yet to be synthesized experimentally.
△ Less
Submitted 24 January, 2020;
originally announced January 2020.
Exploiting tumor shrinkage through temporal optimization of radiotherapy
Authors:
Jan Unkelbach,
David Craft,
Theodore Hong,
David Papp,
Jagdish Ramakrishnan,
Ehsan Salari,
John Wolfgang,
Thomas Bortfeld
Abstract:
In multi-stage radiotherapy, a patient is treated in several stages separated by weeks or months. This regimen has been motivated mostly by radiobiological considerations, but also provides an approach to reduce normal tissue dose by exploiting tumor shrinkage. The paper considers the optimal design of multi-stage treatments, motivated by the clinical management of large liver tumors for which nor…
▽ More
In multi-stage radiotherapy, a patient is treated in several stages separated by weeks or months. This regimen has been motivated mostly by radiobiological considerations, but also provides an approach to reduce normal tissue dose by exploiting tumor shrinkage. The paper considers the optimal design of multi-stage treatments, motivated by the clinical management of large liver tumors for which normal liver dose constraints prohibit the administration of an ablative radiation dose in a single treatment.
We introduce a dynamic tumor model that incorporates three factors: radiation induced cell kill, tumor shrinkage, and tumor cell repopulation. The design of multi-stage radiotherapy is formulated as a mathematical optimization problem in which the total dose to the liver is minimized, subject to delivering the prescribed dose to the tumor. Based on the model, we gain insight into the optimal administration of radiation over time, i.e. the optimal treatment gaps and dose levels.
We analyze treatments consisting of two stages in detail. The analysis confirms the intuition that the second stage should be delivered just before the tumor size reaches a minimum and repopulation overcompensates shrinking. Furthermore, it was found that, for a large range of model parameters, approximately one third of the dose should be delivered in the first stage. The projected benefit of multi-stage treatments depends on model assumptions. However, the model predicts large liver dose reductions by more than a factor of two for plausible model parameters.
The analysis of the tumor model suggests that substantial reduction in normal tissue dose can be achieved by exploiting tumor shrinkage via an optimal design of multi-stage treatments. This suggests taking a fresh look at multi-stage radiotherapy for selected disease sites where substantial tumor regression translates into reduced target volumes.
△ Less
Submitted 9 May, 2014; v1 submitted 22 November, 2013;
originally announced November 2013.
